3rd ANZ Biologics Festival 2025
Excellence in Clinical Trials, Biologics Innovation and Expanded Manufacturing for Australia’s Future Biologics Industry.
With a biotechnology sector benchmarked for global excellence due to world-class facilities, researchers and regulation, Australia has a promising future for biologics innovation and manufacturing. The path ahead will require a focus on further commercial translation of research, and as such partnerships and collaborations will be critical. Expanding sovereign manufacturing in Australia will also play a massive role in uplifting the sector in the country.
The Australia Biologics Festival 2025 is Australia's premier conference that aims to gather the innovators, pioneers ,leaders in the Biologics fraternity including Biologics,Biosimilars, Vaccines, CGT and evolving therapeutics to showcase the latest from ideation to commercialisation phase and beyond. The themes of Investment in Australia and Promoting Clinical Trials in Australia in featured tracks. It brings the right environment to meet the entire biopharma fraternity under one roof.
Join us to bring investment to Australia’s bio sector and explore a wealth of opportunities in world-class clinical trials and biologics innovation as well as expanding the country’s manufacturing footprint.
Limited Super (6th September 2024)
SGD 1,880
Limited Special (1st November 2024)
SGD 2,150
Early Bird (3rd January 2024)
SGD 2,420
Standard Price
SGD 2,690
Limited Group Packages
Poster Presentation:
SGD 400
Site Tour:
SGD 400
Limited Super (6th September 2024)
SGD 3,710
Limited Special (1st November 2024)
SGD 4,040
Early Bird ((3rd January 2024)
SGD 4,250
Standard Price
SGD 4,590
Group Discount for Solution Providers & General Public:
Buy 3 and get 10% off, Buy 5 get 20% off, Buy 6 and above, get 25% off
Site Tour:
SGD 400
Biopharma in Australia and New Zealand is a burgeoning sector, driven by robust research and innovation. The region boasts a strong biotechnology infrastructure, fostering collaborations between academia and industry.
Australia and New Zealand's biopharma companies are actively engaged in developing novel therapies for various diseases, contributing to the global healthcare landscape. Supported by favorable regulatory environments, these nations are attracting investments and establishing themselves as significant players in the biopharmaceutical industry.
At the 2nd Australia Biologics Festival conference, we propose to “feature” the top research work done by the biopharma industry and the academic & research institutes and solution providers from the ANZ region and beyond. The poster presentation will be viewed by 300+ Biopharma industry professionals from top notch biopharma companies.
Some suggested themes for the posters include, but are not limited to:
Abstracts & Poster PDF Submission Guidelines:
On-site Poster Presentation Guidelines:
Very educating and inspiring. I thought that careful thought was put into the topics and time allotted for the presentation
The most representative conference I have been to yet in Australia of the challenges and capabilities of Australian biologics, particularly cell and gene therapy. When I saw 'biologics festival', I thought it would focus mainly on therapeutic recombinant proteins and antibodies, but the spread of gene and cell therapy included was worth attending for!
Greatly appreciated the efforts by the organisers to arrange scheduled meetings with KOLs present at the conference. This was an initiative that I hadn't previously seen take place elsewhere and it allowed for fruitful discussion and engagement between attendees and booth exhibitors.
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2023 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.